News

Recent News on the Federal Circuit

Here is a report on recent news and commentary related to the Federal Circuit and its cases. Today’s report highlights:

  • an article about how “[a] Federal Circuit panel on Tuesday went in circles trying to lock down how a party can disavow part of an exhibit attached to its complaint”;
  • another article about the Federal Circuit holding “raised tariffs on imports of steel derivatives such as nails and fasteners didn’t exceed the scope of the president’s authority”; and
  • a third article about “[c]hipmaking giant Intel Corp. . . . settl[ing] a patent lawsuit brought by wireless technology developer ParkerVision Inc.”
Read More
News

Recent News on the Federal Circuit

Here is a report on recent news and commentary related to the Federal Circuit and its cases. Today’s report highlights:

  • an article about how the “Federal Circuit refused . . . to rehear a challenge to a Delaware judge’s probe into the financing of patent litigation”;
  • another article about “Sanofi and Regeneron on Friday urg[ing] the U.S. Supreme Court to reject Amgen’s arguments that it deserves broad patent coverage on cholesterol drugs”; and
  • a blog post examining the reasons why the “Federal Circuit has ordered [Google’s] case moved out of the Western District of Texas (Waco) to the Northern District of California.”
Read More
News

Recent News on the Federal Circuit

Here is a report on recent news and commentary related to the Federal Circuit and its cases. Today’s report highlights:

  • an article about a Federal Circuit decision finding “[a] Texas federal court ‘clearly abused its discretion’ when declining to transfer a patent-infringement lawsuit against Google LLC”;
  • another article about the Federal Circuit “vacat[ing] what it called an ‘extraordinarily high’ legal-fee award of $185 million”; and
  • a third article about how a “Virginia federal judge issued a bench trial ruling Monday that ImmunoGen is not entitled to a patent on a cancer treatment . . . after the Federal Circuit vacated the court’s previous decision and ordered a trial.”
Read More
News

Recent News on the Federal Circuit

Here is a report on recent news and commentary related to the Federal Circuit and its cases. Today’s report highlights:

  • an article about the potential impact on the value of patents for universities if the Supreme Court grants review in a recent case decided by the Federal Circuit;
  • another article reporting how “U.S. District Judge Alan Albright won’t transfer a cryptographic data technology patent suit against Microsoft Corp.”; and
  • a blog post about a district court finding a patent that “covers a process for allowing users to upload ‘dynamic albums’ to be stored on their devices” to be patent ineligible.
Read More
News / Opinions / Supreme Court Activity

Opinion Summary — Arellano v. McDonough

Last week, the Supreme Court issued its opinion in Arellano v. McDonough, a veterans case that presented the Court with the opportunity to decide whether the one-year statutory deadline for seeking retroactive disability benefits may be equitably tolled. In a unanimous decision, the Court affirmed the Federal Circuit’s ruling, finding that the relevant section of the governing statute is not subject to equitable tolling. Justice Barrett authored the Court’s decision. This is our opinion summary. 

Read More
News

Recent News on the Federal Circuit

Here is a report on recent news and commentary related to the Federal Circuit and its cases. Today’s report highlights:

  • an article about a mandamus petition claiming “U.S. Patent and Trademark Office Director Kathi Vidal ‘unlawfully’ interfered with a patent validity challenge”; and
  • a blog post about the Federal Circuit denying “General Motor’s petition for a writ of mandamus seeking to compel Judge Alan Albright to transfer a patent infringement case.”
Read More
News

Recent News on the Federal Circuit

Here is a report on recent news and commentary related to the Federal Circuit and its cases. Today’s report highlights:

  • a blog post about the U.S. Supreme Court asking the Solicitor General “to provide its views on [a] petition asking the High Court to clarify the proper application of estoppel in inter partes review (IPR) proceedings”;
  • an article about the Federal Circuit rejecting a “claim that the U.S. Supreme Court has implicitly overruled key design patent validity tests”; and
  • another article about the Federal Circuit’s recent en banc decision that “overturned an earlier decision that would have allowed veterans to receive up to an additional year of education.”
Read More
News

Recent News on the Federal Circuit

Here is a report on recent news and commentary related to the Federal Circuit and its cases. Today’s report highlights:

  • an article about how a “Federal Circuit panel . . . seemed wary that . . . large companies used a roundabout way to challenge the U.S. Patent and Trademark Office’s Fintiv policy”;
  • a blog post about a Federal Circuit decision finding that two patents “for remote education and training systems is patent ineligible”; and
  • another article about the Federal Circuit upholding a lower court’s decision related to Amazon.com Inc.’s virtual assistant Alexa.
Read More
News

Recent News on the Federal Circuit

Here is a report on recent news and commentary related to the Federal Circuit and its cases. Today’s report highlights:

  • an article about “a bid by Apple Inc, Google Inc, Intel Corp and others to revive their challenge to a U.S. Patent and Trademark Office policy that made it harder to contest the validity of patents issued by the agency”;
  • another article about the Federal Circuit’s skepticism about “allegations that [Facebook’s] news feed infringed on Usability Sciences’ 2014 patent”; and
  • a blog post about the Federal Circuit denying a petition for a writ of mandamus filed by Amazon.com, Inc.
Read More
News

Recent News on the Federal Circuit

Here is a report on recent news and commentary related to the Federal Circuit and its cases. Today’s report highlights:

  • an article about “[a] Bristol Myers Squibb Co subsidiary on Monday los[ing] a renewed bid for the U.S. Supreme Court to hear its appeal of a 2021 decision that invalidated its cancer-drug patent and overturned a $1.2 billion infringement award it won”; and
  • another article arguing that broad functional patent claims suppress medical innovation.
Read More